tiprankstipranks
Staar Surgical Company (STAA)
NASDAQ:STAA
US Market
STAA
Staar Surgical
RESEARCH TOOLSreports
Want to see STAA full AI Analyst Report?

Staar Surgical (STAA) Stock Forecast & Price Target

570 Followers
See the Price Targets and Ratings of:

STAA Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
2 Buy
5 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Staar
Surgical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

STAA Stock 12 Month Forecast

Average Price Target

$32.60
▲(29.98% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Staar Surgical in the last 3 months. The average price target is $32.60 with a high forecast of $40.00 and a low forecast of $27.00. The average price target represents a 29.98% change from the last price of $25.08.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","28":"$28","41":"$41","21.5":"$21.5","34.5":"$34.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$32.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,21.5,28,34.5,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,30.353846153846156,31.157692307692308,31.961538461538463,32.76538461538462,33.56923076923077,34.37307692307692,35.176923076923075,35.98076923076923,36.784615384615385,37.58846153846154,38.392307692307696,39.19615384615385,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.784615384615385,30.01923076923077,30.253846153846155,30.48846153846154,30.723076923076924,30.95769230769231,31.192307692307693,31.426923076923078,31.661538461538463,31.896153846153847,32.13076923076923,32.36538461538461,{"y":32.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.353846153846156,29.157692307692308,28.961538461538463,28.765384615384615,28.56923076923077,28.373076923076923,28.176923076923078,27.98076923076923,27.784615384615385,27.588461538461537,27.392307692307693,27.196153846153848,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.02,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.76,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.74,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.18,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.87,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.91,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":23.09,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":18.04,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":19.05,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":19.33,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.19,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.55,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$40.00Average Price Target$32.60Lowest Price Target$27.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wedbush Analyst forecast on STAA
Michael Piccolo
Wedbush
Wedbush
$40
Buy
59.49%
Upside
Reiterated
05/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Canaccord Genuity Analyst forecast on STAA
John Young CFA
Canaccord Genuity
Canaccord Genuity
$32
Buy
27.59%
Upside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Staar Surgical (NASDAQ: STAA), Cogent Biosciences (NASDAQ: COGT) and GlaxoSmithKline (NYSE: GSK)
Piper Sandler Analyst forecast on STAA
Adam Maeder
Piper Sandler
Piper Sandler
$16→$33
Hold
31.58%
Upside
Reiterated
05/14/26
Staar Surgical price target raised to $33 from $16 at Piper SandlerStaar Surgical price target raised to $33 from $16 at Piper Sandler
Mizuho Securities Analyst forecast on STAA
Anthony Petrone
Mizuho Securities
Mizuho Securities
$22→$27
Hold
7.66%
Upside
Reiterated
05/14/26
Staar Surgical price target raised to $27 from $22 at MizuhoStaar Surgical price target raised to $27 from $22 at Mizuho
Stifel Nicolaus Analyst forecast on STAA
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
$18→$31
Hold
23.60%
Upside
Reiterated
05/14/26
Staar Surgical price target raised to $31 from $18 at StifelStaar Surgical price target raised to $31 from $18 at Stifel
BTIG Analyst forecast on STAA
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
05/14/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (NASDAQ: STAA), Halozyme (NASDAQ: HALO) and Vor Biopharma (NASDAQ: VOR)
Needham Analyst forecast on STAA
David Saxon
Needham
Needham
―
Hold
―
Reiterated
05/14/26
Analyst Maintains Hold on Staar Surgical Amid Stable Trends but Limited Visibility Into 2026 Outlook
Morgan Stanley Analyst forecast on STAA
Patrick Wood
Morgan Stanley
Morgan Stanley
$13
Sell
-48.17%
Downside
Reiterated
03/11/26
Morgan Stanley Reaffirms Their Sell Rating on Staar Surgical (STAA)
Stephens Analyst forecast on STAA
Unknown Analyst
Stephens
Not Ranked
Stephens
$28
Hold
11.64%
Upside
Reiterated
03/04/26
Stephens Sticks to Its Hold Rating for Staar Surgical (STAA)
Jefferies Analyst forecast on STAA
Raj Denhoy
Jefferies
Jefferies
$21→$28
Hold
11.64%
Upside
Reiterated
08/06/25
Jefferies Remains a Hold on Staar Surgical (STAA)
Sidoti Analyst forecast on STAA
James Sidoti
Sidoti
Sidoti
$27→$28
Hold
11.64%
Upside
Downgraded
08/05/25
Staar Surgical downgraded to Neutral from Buy at SidotiStaar Surgical downgraded to Neutral from Buy at Sidoti
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wedbush Analyst forecast on STAA
Michael Piccolo
Wedbush
Wedbush
$40
Buy
59.49%
Upside
Reiterated
05/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Canaccord Genuity Analyst forecast on STAA
John Young CFA
Canaccord Genuity
Canaccord Genuity
$32
Buy
27.59%
Upside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Staar Surgical (NASDAQ: STAA), Cogent Biosciences (NASDAQ: COGT) and GlaxoSmithKline (NYSE: GSK)
Piper Sandler Analyst forecast on STAA
Adam Maeder
Piper Sandler
Piper Sandler
$16→$33
Hold
31.58%
Upside
Reiterated
05/14/26
Staar Surgical price target raised to $33 from $16 at Piper SandlerStaar Surgical price target raised to $33 from $16 at Piper Sandler
Mizuho Securities Analyst forecast on STAA
Anthony Petrone
Mizuho Securities
Mizuho Securities
$22→$27
Hold
7.66%
Upside
Reiterated
05/14/26
Staar Surgical price target raised to $27 from $22 at MizuhoStaar Surgical price target raised to $27 from $22 at Mizuho
Stifel Nicolaus Analyst forecast on STAA
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
$18→$31
Hold
23.60%
Upside
Reiterated
05/14/26
Staar Surgical price target raised to $31 from $18 at StifelStaar Surgical price target raised to $31 from $18 at Stifel
BTIG Analyst forecast on STAA
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
05/14/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (NASDAQ: STAA), Halozyme (NASDAQ: HALO) and Vor Biopharma (NASDAQ: VOR)
Needham Analyst forecast on STAA
David Saxon
Needham
Needham
―
Hold
―
Reiterated
05/14/26
Analyst Maintains Hold on Staar Surgical Amid Stable Trends but Limited Visibility Into 2026 Outlook
Morgan Stanley Analyst forecast on STAA
Patrick Wood
Morgan Stanley
Morgan Stanley
$13
Sell
-48.17%
Downside
Reiterated
03/11/26
Morgan Stanley Reaffirms Their Sell Rating on Staar Surgical (STAA)
Stephens Analyst forecast on STAA
Unknown Analyst
Stephens
Not Ranked
Stephens
$28
Hold
11.64%
Upside
Reiterated
03/04/26
Stephens Sticks to Its Hold Rating for Staar Surgical (STAA)
Jefferies Analyst forecast on STAA
Raj Denhoy
Jefferies
Jefferies
$21→$28
Hold
11.64%
Upside
Reiterated
08/06/25
Jefferies Remains a Hold on Staar Surgical (STAA)
Sidoti Analyst forecast on STAA
James Sidoti
Sidoti
Sidoti
$27→$28
Hold
11.64%
Upside
Downgraded
08/05/25
Staar Surgical downgraded to Neutral from Buy at SidotiStaar Surgical downgraded to Neutral from Buy at Sidoti
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Staar Surgical

3 Months
Patrick WoodMorgan Stanley
Success Rate
4/7 ratings generated profit
57%
Average Return
-0.06%
Copying Patrick Wood's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of -0.06% per trade.
1 Year
Patrick WoodMorgan Stanley
Success Rate
4/7 ratings generated profit
57%
Average Return
-2.09%
Copying Patrick Wood's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of -2.09% per trade.
2 Years
Patrick WoodMorgan Stanley
Success Rate
3/7 ratings generated profit
43%
Average Return
-21.31%
Copying Patrick Wood's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -21.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

STAA Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
0
0
1
5
5
Hold
13
19
19
20
10
Sell
1
2
1
1
0
Strong Sell
0
0
0
0
0
total
14
21
21
26
15
In the current month, STAA has received 5 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. STAA average Analyst price target in the past 3 months is 32.60.
Each month's total comprises the sum of three months' worth of ratings.

STAA Financial Forecast

STAA Earnings Forecast

Next quarter’s earnings estimate for STAA is $0.22 with a range of $0.05 to $0.34. The previous quarter’s EPS was $0.41. STAA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year STAA has Performed in-line its overall industry.
Next quarter’s earnings estimate for STAA is $0.22 with a range of $0.05 to $0.34. The previous quarter’s EPS was $0.41. STAA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year STAA has Performed in-line its overall industry.

STAA Sales Forecast

Next quarter’s sales forecast for STAA is $90.17M with a range of $86.70M to $98.20M. The previous quarter’s sales results were $93.52M. STAA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year STAA has Performed in-line its overall industry.
Next quarter’s sales forecast for STAA is $90.17M with a range of $86.70M to $98.20M. The previous quarter’s sales results were $93.52M. STAA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year STAA has Performed in-line its overall industry.

STAA Stock Forecast FAQ

What is STAA’s average 12-month price target, according to analysts?
Based on analyst ratings, Staar Surgical Company’s 12-month average price target is 32.60.
    What is STAA’s upside potential, based on the analysts’ average price target?
    Staar Surgical Company has 29.98% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is STAA a Buy, Sell or Hold?
          Staar Surgical Company has a consensus rating of Moderate Buy which is based on 2 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Staar Surgical Company’s price target?
            The average price target for Staar Surgical Company is 32.60. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $40.00 ,the lowest forecast is $27.00. The average price target represents 29.98% Increase from the current price of $25.08.
              What do analysts say about Staar Surgical Company?
              Staar Surgical Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of STAA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.